Balanced news tone
News Sentiment
CDNA sentiment intelligence
CareDx Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
52
Balanced news tone
50 relevant articles
News tone and price action are not far from neutral.
85/100 classification confidence.
directly relevant articles
high-authority source matches
-2.3% over one week, +24.1% over four weeks, trend active, and materially above fair value.
How Caredx Inc. (CDNA) Affects Rotational Strategy Timing
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
85/100 classification
One-week reaction
-2.3%
Price reacting lower
Trend fit
Trend active
24.1% over four weeks
Fair value
68.6%
Materially above fair value
Sentiment Mix
Positive, neutral, negative
Positive
12
Neutral
32
Negative
6
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
simplywall.st
Direct company coverage
CareDx (CDNA) Stock Could Be 1.5% Overvalued After AlloSure Study Buzz
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Jun 2026 07:00
- Source
- simplywall.st
ChartMill
Direct company coverage
CareDx (NASDAQ:CDNA) Passes Both the Minervini Trend Template and High Growth Momentum Tests
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 20 Jun 2026 07:00
- Source
- ChartMill
Market source
Direct company coverage
CareDx (CDNA) Moves 11.5% Higher: Will This Strength Last?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 19 Jun 2026 07:00
- Source
- Market source
simplywall.st
Direct company coverage
How New AlloSure Kidney Prognostic Evidence At CareDx (CDNA) Has Changed Its Investment Story
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jun 2026 07:00
- Source
- simplywall.st
Business Wire
Direct company coverage
CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 11:05
- Source
- Business Wire
Investing.com Canada
Direct company coverage
CareDx presents transplant monitoring data at medical congress By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 07:00
- Source
- Investing.com Canada
Stock Titan
Direct company coverage
CareDx (CDNA) CEO sells 17,683 shares under 10b5-1 plan
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 07:00
- Source
- Stock Titan
MT Newswires
Direct company coverage
Caredx Insider Sold Shares Worth $279,728, According to a Recent SEC Filing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 21:57
- Source
- MT Newswires
Stock Titan
Direct company coverage
CareDx (CDNA) director logs RSU grant and pre-planned share sale
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
CareDx AlloSure data point to earlier warning signs for kidney transplants
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 16 Jun 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
[144] CareDx, Inc. SEC Filing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 07:00
- Source
- Stock Titan
Market source
Direct company coverage
A Look At CareDx (CDNA) Valuation After Recent Share Price Momentum Cools
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 May 2026 07:00
- Source
- Market source
simplywall.st
Direct company coverage
CareDx (CDNA) Returns To Quarterly Profit Challenging Skepticism Around Its Earnings Story
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 30 Apr 2026 07:00
- Source
- simplywall.st
Stock Titan
Direct company coverage
New CareDx test delivers HLA and blood typing in under 3 hours
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Apr 2026 07:00
- Source
- Stock Titan
Market source
Direct company coverage
Assessing CareDx (CDNA) Valuation After Recent Share Price Momentum And Mixed Long Term Returns
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Apr 2026 07:00
- Source
- Market source
Stock Titan
Direct company coverage
Proposed CDNA common sales; John Hanna 10b5-1 trades (NASDAQ: CDNA)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Apr 2026 07:00
- Source
- Stock Titan
Investing.com
Direct company coverage
CareDx to sell lab products unit for $170 million in cash
- Tone
- Negative 34/100
- Event
- Balance sheet
- Published
- 15 Apr 2026 07:00
- Source
- Investing.com
Market source
Direct company coverage
How The CareDx (CDNA) Investment Story Is Shifting With New Targets And Policy Risks
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 15 Apr 2026 07:00
- Source
- Market source
simplywall.st
Direct company coverage
CareDx, Inc's (NASDAQ:CDNA) Shares Bounce 25% But Its Business Still Trails The Industry
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Nov 2025 08:00
- Source
- simplywall.st
Nanalyze
Direct company coverage
CareDx Stock is Pure Play on Organ Transplant Diagnostics
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Nov 2022 08:00
- Source
- Nanalyze